BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1056 related articles for article (PubMed ID: 23371445)

  • 1. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
    Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
    Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.
    Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Tonami N; Hisada K
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):195-202. PubMed ID: 15449050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of LVEF assessed by 2D echocardiography, gated blood pool SPECT, 99mTc tetrofosmin gated SPECT, and 18F-FDG gated PET with ERNV in patients with CAD and severe LV dysfunction.
    Raja S; Mittal BR; Santhosh S; Bhattacharya A; Rohit MK
    Nucl Med Commun; 2014 Nov; 35(11):1156-61. PubMed ID: 25144559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gated N-13 ammonia PET and gated Tc-99m sestamibi SPECT for quantitative analysis of global and regional left ventricular function.
    Kanayama S; Matsunari I; Kajinami K
    J Nucl Cardiol; 2007; 14(5):680-7. PubMed ID: 17826321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.
    Slart RH; Bax JJ; de Boer J; Willemsen AT; Mook PH; Oudkerk M; van der Wall EE; van Veldhuisen DJ; Jager PL
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):972-9. PubMed ID: 15824927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Irwan R; Sluiter WJ; Dierckx RA; de Boer J; Jager PL
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):716-23. PubMed ID: 16523309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of left ventricular volumes, ejection fraction and mass. Comparison of model-based analysis of ECG-gated (⁹⁹m)Tc-SPECT and ¹⁸F-FDG-PET.
    Khorsand A; Gyöngyösi M; Sochor H; Maurer G; Karanikas G; Dudczak R; Schuster E; Porenta G; Graf S
    Nuklearmedizin; 2011; 50(1):9-14. PubMed ID: 21165540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPECT: MRI validation and comparison of the Emory Cardiac Tool Box with QGS and 4D-MSPECT.
    Schaefer WM; Lipke CS; Standke D; Kühl HP; Nowak B; Kaiser HJ; Koch KC; Buell U
    J Nucl Med; 2005 Aug; 46(8):1256-63. PubMed ID: 16085580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left-ventricular dyssynchrony evaluated by Tl-201 gated SPECT myocardial perfusion imaging: a comparison with Tc-99m sestamibi.
    Chen CC; Huang WS; Hung GU; Chen WC; Kao CH; Chen J
    Nucl Med Commun; 2013 Mar; 34(3):229-32. PubMed ID: 23238227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of nitrate augmented Tc-99m tetrofosmin gated SPECT imaging with FDG PET imaging for the assessment of myocardial viability in patients with severe left ventricular dysfunction.
    Raja S; Singh B; Rohit MK; Manohar K; Kashyap R; Bhattacharya A; Mittal BR
    J Nucl Cardiol; 2012 Dec; 19(6):1176-81. PubMed ID: 22872319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT.
    Slart RH; Bax JJ; Sluiter WJ; van Veldhuisen DJ; Jager PL
    J Nucl Cardiol; 2004; 11(6):689-96. PubMed ID: 15592192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
    Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Takekoshi N; Tonami N; Hisada K
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1357-64. PubMed ID: 12271419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
    Wu YW; Tadamura E; Yamamuro M; Kanao S; Marui A; Tanabara K; Komeda M; Togashi K
    J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OSEM reconstruction, associated with temporal fourier and depth-dependant resolution recovery filtering, enhances results from sestamibi and 201Tl 16-interval gated SPECT.
    Marie PY; Djaballah W; Franken PR; Vanhove C; Muller MA; Boutley H; Poussier S; Olivier P; Karcher G; Bertrand A
    J Nucl Med; 2005 Nov; 46(11):1789-95. PubMed ID: 16269591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of 4D-MSPECT and QGS for quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPET: comparison with cardiac magnetic resonance imaging.
    Lipke CS; Kühl HP; Nowak B; Kaiser HJ; Reinartz P; Koch KC; Buell U; Schaefer WM
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):482-90. PubMed ID: 14722679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
    Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
    J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac death in patients with left ventricular aneurysm, remodeling and myocardial viability by gated
    Wang W; Li X; Tian C; Zhao S; Hacker M; Zhang X
    Int J Cardiovasc Imaging; 2018 Mar; 34(3):485-493. PubMed ID: 28823060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging.
    Giorgetti A; Marzullo P; Sambuceti G; Di Quirico S; Kusch A; Landi P; Salvadori PA; Pisani P; L'abbate A
    J Nucl Cardiol; 2004; 11(2):142-51. PubMed ID: 15052245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI.
    Schaefer WM; Lipke CS; Nowak B; Kaiser HJ; Reinartz P; Buecker A; Krombach GA; Buell U; Kühl HP
    J Nucl Med; 2004 Jan; 45(1):74-9. PubMed ID: 14734676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of myocardial viability with (99m)Tc-sestamibi -gated SPET images in patients undergoing percutaneous transluminar coronary angioplasty.
    Tzonevska A; Tzvetkov K; Dimitrova M; Piperkova E
    Hell J Nucl Med; 2005; 8(1):48-53. PubMed ID: 15886754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.